Aptose Enters into $25 Million Committed Equity Facility and Establishes New At-The-Market ...
Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company ...
Aptose Biosciences secures $25 million equity facility
Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage company focusing on precision oncology treatments, announced today that it has entered into financial agreements to potentially increase its capital.
EurekAlert!5 天
Investigating the health benefits of omega-3 from fish eggs
Anglia Ruskin University (ARU) in Cambridge, England, has teamed up with Norwegian biotech company Arctic Bioscience to conduct the largest research project to date on the health benefits of omega-3 ...